Table 1.

Characteristics of n=93 study participants

Characteristic, n=93	n (%)	High SIIV intent n (%)	P values
Gender
Male	49 (52.7)	40 (81.6)
Female	44 (47.3)	31 (70.5)	0.23
Age group
16–34	22 (23.7)	15 (68.2)
35–54	36 (38.7)	33 (91.7)
55–64	20 (21.5)	15 (75)
65+	15 (16.1)	8 (53.5)	0.02*
HSCT type
Allogeneic	73 (78.5)	59 (80.8)
Autologous	20 (21.5)	15 (75)	0.78
Disease indication
Acute lymphoblastic leukaemia	11 (11.8)	8 (72.7)
Acute myeloid leukaemia	26 (28.0)	20 (76.9)
Aplastic anaemia	5 (5.4)	3 (60)
Chronic myeloid leukaemia	5 (5.4)	5 (100)
Hodgkin lymphoma	9 (9.7)	9 (88.9)
Myelodysplastic syndrome	5 (5.4)	3 (60)
Myelofibrosis	2 (2.2)	1 (50)
Multiple myeloma	22 (23.7)	17 (77.3)
Non-Hodgkin’s lymphoma	8 (8.6)	6 (75)	0.79
Months from HSCT
0–6	64 (68.8)	52 (81.3)
>6–12	20 (21.5)	14 (70)
>12	9 (9.7)	5 (55.6)	0.18
SIIV before HSCT
Yes	38 (40.9)	34 (89.5)
No	55 (59.1)	37 (67.3)	0.01*
Any non-SIIV vaccine since HSCT
Yes	4 (4.3)	4 (100)
No	89 (95.7)	67 (75.3)	0.26
Ethnicity
White	79 (84.9)	69 (77.2)
Asian	8 (8.6)	7 (87.5)
Black	3 (3.2)	2 (66.7)
Mixed	2 (2.2)	1 (50)
Other	1 (1.1)	0 (0)	0.32
Educational background
Higher education	30 (32.3)	24 (80)
Secondary education	49 (52.7)	40 (81.6)
Other	3 (3.2)	2 (66.7)
Prefer not to answer	11 (11.8)	5 (45.5)	0.07
Living circumstances
Renting	25 (26.9)	33 (76)
Home owner	54 (58.1)	43 (79.6)
Other	10 (10.8)	7 (70)
Prefer not to answer	4 (4.7)	2 (50)	0.56
Relationship status
Single	23 (24.7)	18 (78.3)
Married/cohabiting	56 (60.2)	45 (80.4)
Divorced/separated	10 (10.8)	5 (50)
Prefer not to answer	4 (4.4)	3 (75)	0.22

*Statistically significant (p<0.05).

HSCT, haematopoietic stem cell transplant; SIIV, seasonal inactivated influenza vaccine.